Searched over 200M research papers
10 papers analyzed
Some studies suggest low blood pressure in acute stroke patients is associated with worse outcomes and increased adverse events, while other studies indicate that lowering blood pressure can reduce the risk of stroke and coronary heart disease.
20 papers analyzed
Low blood pressure (BP) during an acute ischemic stroke (AIS) is a critical factor that can significantly impact patient outcomes. While high BP is commonly associated with stroke, low BP is less frequent but poses substantial risks. This article synthesizes current research to elucidate the symptoms and outcomes associated with low BP in stroke patients.
Research indicates that low BP in AIS patients is linked to poor functional outcomes and increased mortality. A study involving 11,083 patients found that those with low systolic blood pressure (SBP) had worse functional outcomes and higher rates of serious adverse events (SAEs), particularly cardiac events. Another study corroborated these findings, showing that low SBP at presentation was associated with increased in-hospital mortality and complications such as heart failure, gastrointestinal bleeding, and sepsis.
The relationship between BP and stroke outcomes often follows a J-shaped curve. Both low and high BP are associated with poor outcomes, but the risks are particularly pronounced at the extremes. For instance, a meta-regression analysis of 37 trials involving 9,008 patients found that both significant increases and decreases in BP were linked to worse outcomes, with the lowest odds of early death occurring at a modest BP reduction. This J-shaped relationship underscores the complexity of BP management in stroke patients.
Low BP in stroke patients is also associated with an increased risk of cardiac events. The International Stroke Trial (IST) found that low SBP was linked to a higher incidence of deaths from coronary heart disease. This association suggests that low BP may exacerbate underlying cardiovascular conditions, leading to worse outcomes.
In some cases, increasing BP might benefit patients with post-stroke hypotension. A systematic review of 27 studies involving 1,886 patients explored the use of vasopressors to elevate BP in AIS patients. While BP elevation was feasible and potentially beneficial in certain scenarios, the effects on functional outcomes were largely unknown, and close monitoring was advised.
Given the diverse mechanisms influencing BP changes during AIS, individualized BP management protocols are recommended. Factors such as the presence of arterial hypertension, comorbid organ dysfunction, and the degree of reperfusion achieved should inform therapeutic decisions. Recent data suggest that targeting person-specific local cerebral perfusion and metabolic demand, rather than global BP parameters alone, may be a valuable approach.
Low blood pressure in acute ischemic stroke patients is associated with significant risks, including poor functional outcomes, increased mortality, and higher rates of cardiac events. The relationship between BP and stroke outcomes is complex, often following a J-shaped curve. While elevating BP may benefit some patients, individualized management protocols are essential to optimize outcomes. Further research is needed to refine BP management strategies and identify the most effective interventions for AIS patients with low BP.
Most relevant research papers on this topic